Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSA vs ICB for Forearm Fracture Reduction
NCT06588907Completed
- Sponsor
- Ankara Etlik City Hospital
- Start
- Jun 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Forearm Fracture comparing PSA (Ketamine) with ICB (Bupivacaine) (2 arms). Primary endpoints: Numeric Rating Scale Pain Score at 24 hours, Success of Reduction Procedure at 1 hour and 1 more. Started Jun 2024; status: completed.
02
Drugs
ketaminebupivacaine hydrochloride 0.75% injection
03
Conditions
Forearm Fracture
Beyond the preview
Go deeper on NCT06588907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06588907.